Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.
about
Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)Evidence of Recombination in Intrapatient Populations of Hepatitis C VirusEmergence of recombinant forms of HIV: dynamics and scalingExtensive HIV-1 intra-host recombination is common in tissues with abnormal histopathologyStochastic simulations suggest that HIV-1 survives close to its error thresholdIdentifying the important HIV-1 recombination breakpoints.Serial evolutionary networks of within-patient HIV-1 sequences reveal patterns of evolution of X4 strains.Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1The evolution of HIV: inferences using phylogenetics.Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Genetic Consequences of Antiviral Therapy on HIV-1.The Role of Recombination in Evolutionary Rescue.HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.The emergence of drug resistant HIV variants and novel anti-retroviral therapy.Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.Altered strand transfer activity of a multiple-drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutant with a dipeptide fingers domain insertion.The evolutionary epidemiology of multilocus drug resistance.Genetic diversity and molecular epidemiology of HIV transmission
P2860
Q24645606-E0AEB3AF-C1D4-4373-BD7F-EB5C20FCF289Q27486806-92A7D5C3-8ED1-4B9A-859F-ECAEE3CA40C0Q28469341-ECAB0631-2593-4384-A8AD-D6B16D1EA34CQ28475143-79E61CD1-162F-4E8C-B41C-219A95995DD2Q28483749-28D0E063-C167-4C79-81A6-10C2E6200EEEQ30372035-FEAF732E-F6C1-4642-8B9A-1884F76BEEBFQ33468625-9554789B-2AAD-4230-A5F8-B0FB12A1C194Q33797892-393441D4-790F-44B9-A1CC-8B7E2A80C2BAQ35671910-12385789-EB27-4260-98C0-A3C1310BC714Q35699612-F016E21A-E3C7-44A6-A4E7-51909ADE9164Q35773113-AA169BF4-49EA-4A54-B254-E2FEC4D95CBDQ35858028-92EF7787-5196-4163-A357-0E110EF32DE6Q36412256-B78A74FD-2E08-499B-82FC-A8CA172D5C14Q36963496-0B41BD0F-E668-41FB-9895-16921F350422Q37350895-40D15CDC-AC14-4E52-B461-24A687275590Q41760939-985576A7-F12B-414F-80CB-1F423BE7BAE6Q41911362-5BE4DE82-6FA7-4D7A-971D-2785115CA179Q45344370-271FEED4-3856-4EE2-BE5A-688F77E5F93EQ57196807-02D87BC0-AF8A-40D9-BE11-2411AB362F62
P2860
Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Recombination favors the evolu ...... during antiretroviral therapy.
@ast
Recombination favors the evolu ...... during antiretroviral therapy.
@en
type
label
Recombination favors the evolu ...... during antiretroviral therapy.
@ast
Recombination favors the evolu ...... during antiretroviral therapy.
@en
prefLabel
Recombination favors the evolu ...... during antiretroviral therapy.
@ast
Recombination favors the evolu ...... during antiretroviral therapy.
@en
P2860
P50
P1476
Recombination favors the evolu ...... during antiretroviral therapy.
@en
P2860
P304
P356
10.1016/J.MEEGID.2007.02.001
P577
2007-02-12T00:00:00Z